Safety and Effectiveness of D-serine in Schizophrenia

Completed · Phase 2

Conditions studied: Schizophrenia

In brief

This study will determine whether increasing D-serine within the body will improve negative symptoms and cognitive impairments in people with schizophrenia.

Key facts

Study ID
NCT00322023
Run by
Nathan Kline Institute for Psychiatric Research
People needed
55
Starts
2006-03-01
Expected to finish
2009-01-01
Last updated by the study team
2020-10-05

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.